Get startedLog in
    Picture of Active Biotech AB publ logo

    ACTI — Active Biotech AB publ News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Active Biotech Says Naptumomab, Docetaxel Results To Be Presented At ASCO 2024

    Picture of Active Biotech AB publ logoActive Biotech AB publ
    28/05/2024 07:06
    May 28 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * CLINICAL ACTIVITY AND SAFETY OF NAPTUMOMAB AND DOCETAXEL
TO BE
PRESENTED AT ASCO 2024

Source text for Eikon:  ID:nMFNBZML8 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Active Biotech AB publ

    See all news